GroundForce Capital Announces Growth Investment in Epicutis
GroundForce Capital Announces Growth Investment in Epicutis
Investment will fuel continued expansion of Epicutis's science-backed, professional-channel skincare platform
IRVINE, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--GroundForce Capital (“GroundForce”) today announced a growth investment in Signum Dermalogix, Inc. (“Epicutis” or the “Company”), a science-backed, IP-driven skincare brand built around patented, biotechnology-derived actives. The investment supports Epicutis's next phase of growth across the professional dermocosmetics channel, where the Company has built a fast-growing footprint among medspas, dermatology practices and luxury spas.
GroundForce Capital Announces Growth Investment in Epicutis. Investment will fuel continued expansion of Epicutis's science-backed, professional-channel skincare platform.
Share
Founded out of more than 20 years of bioscience research affiliated with Princeton University through Signum Biosciences, Epicutis develops clean, minimalist formulations built around its “Skin Health” positioning and proprietary, patent-protected actives, including TSC, DSD and HYVIA®. The brand has built its reputation within the professional channel, where practitioner trust has underpinned its growth, and has attracted growing recognition within the beauty industry along the way.
Epicutis has scaled revenue at nearly a 100% compound annual growth rate over the past two years, driven by increasing adoption among skincare professionals and a scalable, high-performing sales organization built over the past several years. The Company expects to continue on this strong growth trajectory, capitalizing on industry tailwinds as consumers increasingly look to professionals for product recommendations and the professional channel continues seeing momentum. This investment will enable the company to continue building brand awareness, developing cutting edge skincare innovation, and delivering best-in-class products to their consumers.
“Epicutis exists because we believed skincare deserved real science — actives discovered in the lab, published in the literature, and trusted by practitioners before they ever reach a shelf,” said Maxwell Stock, Co-Founder, CEO and President of Epicutis. “GroundForce understood that discipline from our very first conversation. This partnership lets us move faster on everything that matters: the discovery pipeline behind the brand, the professional channel we intend to lead, and the standard of proof we hold ourselves to.”
“Epicutis has built something rare in skincare: a genuinely differentiated scientific platform paired with the sales execution to bring it to market at scale,” said Dan Gluck, Co-Founder and Co-Managing Partner of GroundForce Capital. “Max and the team have earned the trust of practitioners the hard way, one account at a time, and we're proud to back that discipline as Epicutis enters its next phase of growth.”
As part of the investment, GroundForce will join Epicutis's board of directors.
DC Advisory served as exclusive financial advisor to Epicutis.
About Epicutis
Epicutis is a science-backed skincare brand built around its “Skin Health” positioning, offering clean, traceable, minimal formulations developed from proprietary, patent-protected actives. Born from more than 20 years of research through its affiliate Signum Biosciences, Epicutis is the only fully EWG Verified® skincare line built exclusively for the professional channel, with over 4,100+ active professional accounts across medspas, dermatology practices and spas nationwide. For more information, visit epicutis.com.
About GroundForce Capital
GroundForce Capital is a founder-led investment firm backing the bold brands, technology, and services driving the future of consumer products. Guided by decades of operating and investing experience, the firm brings a founder's mindset, strategic discipline, creativity, and deep industry expertise. GroundForce Capital goes beyond providing capital, offering hands-on collaboration, strategic guidance, and a powerful network of industry leaders, operators, and advisors.
GroundForce Capital's portfolio includes category-defining brands such as Bobbie, Liquid Death, SYSTM Foods, OWYN, Vive Organic, Righteous Felon, ZICO, and Thistle. GroundForce Capital's leadership team previously built and scaled iconic modern food and beverage companies including ZICO Beverages, acquired by The Coca-Cola Company, and Health Warrior, acquired by PepsiCo. For more information, please visit groundforcecapital.com.
